-
Article | 2020.07.07
LuLISA project, bioluminescence as a tool for human diagnostics, from allergy to Covid19
LuLISA project, bioluminescence as a tool for human diagnostics, from allergy to Covid19
-
Article | 2020.07.07
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
-
Article | 2020.07.07
COVID-19: mathematical model indicates that between 3% and 7% of French people have been infected
COVID-19: mathematical model indicates that between 3% and 7% of French people have been infected
-
Article | 2020.07.07
COVID-19 - The Bioinformatics and Biostatistics Hub on the front line
COVID-19 - The Bioinformatics and Biostatistics Hub on the front line
-
News | 2020.07.09
Sleeping sickness: one step further in improving diagnosis
The African trypanosome Trypanosoma brucei gambiense is a parasite responsible for chronic Human African Trypanosomiasis, more commonly known as sleeping sickness. Diagnosing sleeping sickness generally involves two stages: serological screening (to search for antibodies against parasites in the bloodstream), followed by the microscopic detection of live parasites in the blood or a lymph node...
-
Document de presse | 2020.07.06
COVID-19: no cross-protective immunity conferred by other coronaviruses in children
Every winter, seasonal coronaviruses are responsible for repeated colds and bronchitis from early childhood onwards. The question of whether the four seasonal coronaviruses can confer cross-protective immunity for COVID-19 was recently raised when it was demonstrated that some individuals had antibodies and immunity cells recognizing the SARS-CoV-2 virus before it was in active circulation. The...
-
Document de presse | 2020.07.15
Type 1 Interferon deficiency: A blood based Signature for Detecting Patients at risk of severe Covid-19 for a therapeutic approach
Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of patients. In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting...
-
News | 2020.07.21
Chikungunya: the specific interactions between the genotypes of mosquitoes and viruses have influenced Ae. albopictus vector competence for the virus
With the help of a genetic structure analysis carried out on 25 Ae. albopictus mosquito populations covering all continents, scientists demonstrate that the demographic history of Ae. albopictus has shaped the vector competence of these populations. This information is essential to better estimate the risks of chikungunya emergence in Europe.Who has not heard of the tiger mosquito? Summer is its...
-
News | 2020.07.24
Viral sequence integrated in mosquito genome controls infection by related virus
A new endogenous viral element (EVE) has been identified in Aedes aegypti mosquitoes. This EVE is almost identical to a contemporaneous strain of cell-fusing agent virus (CFAV), a widespread insect-specific virus found in Ae. aegypti populations. Researchers experimentally demonstrated that this EVE controls CFAV replication in the mosquito’s ovaries. This discovery supports the idea that EVEs...
-
Page avancée | 2020.07.27
Innovation
The Institut Pasteur, a private and non-profit foundation, is a place where both basic research programs and technology transfer are supported in order to fulfill our four missions : research, public health, education and the identification of research applications. The Institut Pasteur is in a unique position to develop partnerships with industry to face public health challenges and...
